Table 1.
Baseline patient characteristics of patients treated with DCB or DES
| Characteristic | DCB, N = 544 | DES, N = 693 | p value |
|---|---|---|---|
| Age, median (IQR) | 69 (61–75) | 69 (61–75) | 0.611 |
| Male, n (%) | 429 (79) | 541 (78) | 0.742 |
| Current/ex-smoker, n (%) | 336 (62) | 455 (66) | 0.112 |
| Hypercholesterolaemia, n (%) | 186 (34) | 224 (32) | 0.492 |
| Hypertension, n (%) | 307 (56) | 397 (57) | 0.762 |
| Peripheral vascular disease, n (%) | 24 (4.4) | 33 (4.8) | 0.772 |
| Cerebrovascular disease, n (%) | 42 (7.7) | 37 (5.3) | 0.0892 |
| Myocardial infarction, n (%) | 93 (17) | 123 (18) | 0.762 |
| Percutaneous coronary intervention, n (%) | 79 (15) | 86 (12) | 0.282 |
| Coronary artery bypass graft, n (%) | 47 (8.6) | 56 (8.1) | 0.722 |
| Atrial fibrillation, n (%) | 56 (10) | 52 (7.5) | 0.0842 |
| Heart failure, n (%) | 18 (3.3) | 20 (2.9) | 0.672 |
| Chronic obstructive pulmonary disease, n (%) | 18 (3.3) | 44 (6.3) | 0.0152 |
| Diabetes, n (%) | 125 (23) | 153 (22) | 0.712 |
| Family history, n (%) | 148 (27) | 174 (25) | 0.402 |
| eGFR (ml/min/1.73 m2) median (IQR) | 79 (66–91) | 78 (67–91) | 0.851 |
| Frailty, n (%) | > 0.993 | ||
| Low | 541 (99) | 688 (99) | |
| Intermediate | 3 (0.6) | 5 (0.7) | |
| High | 0 (0) | 0 (0) |
Data are n (%) or median (IQR)
DCB drug-coated balloon, DES drug-eluting stent, eGFR estimated glomerular filtration rate, eGFR estimated glomerular filtration rate
1Wilcoxon rank sum test
2Pearson's Chi-squared test
3Fisher's exact test
4Wilcoxon rank sum exact test
Bold indicate significant result